HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR ARRESTS THE CELL-CYCLE IN G(2) BY INHIBITING THE ACTIVATION OF P34(CDC2)-CYCLIN-B

被引:334
|
作者
RE, F
BRAATEN, D
FRANKE, EK
LUBAN, J
机构
[1] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032
关键词
D O I
10.1128/JVI.69.11.6859-6864.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) vpr inhibits the replication of tumor cell lines and peripheral blood mononuclear cells. Here it is demonstrated that expression of vpr, either in the context of a provirus or from an independent genetic element, induces a discrete cell cycle arrest, with cells containing 4N DNA. Low cyclin B-associated kinase activity, as well as the status of p34(cdc2) and cdc25C phosphorylation, indicates that the cascade of reactions which drives the cell into mitosis has not been initiated, The phosphatase inhibitor okadaic acid releases the block, suggesting that Vpr perturbs upstream regulators of the G(2)-M transition. These studies demonstrate that HIV-1 vpr has profound effects on the cellular factors which control entry into mitosis and indicate vpr's potential contribution to the cellular pathology associated with HIV-1 infection.
引用
收藏
页码:6859 / 6864
页数:6
相关论文
共 50 条
  • [21] Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
    Piedimonte, G
    Corsi, D
    Paiardini, M
    Cannavò, G
    Ientile, R
    Picerno, I
    Montroni, M
    Silvestri, G
    Magnani, M
    AIDS, 1999, 13 (10) : 1159 - 1164
  • [22] ONCOGENIC RAS BLOCKS CELL-CYCLE PROGRESSION AND INHIBITS P34(CDC2) KINASE IN ACTIVATED XENOPUS EGG EXTRACTS
    PAN, BT
    CHEN, CT
    LIN, SM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (08) : 5968 - 5975
  • [23] BREAKDOWN OF CELL-CYCLE CHECKPOINTS REQUIRES LACK OF BIME AND NONTYROSINE PHOSPHORYLATED P34(CDC2) WHICH ACTIVATE NIMA
    YE, X
    FINCHER, R
    TANG, A
    OSMANI, S
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 29 - 29
  • [24] RAPAMYCIN INHIBITS P34(CDC2) EXPRESSION AND ARRESTS T-LYMPHOCYTE PROLIFERATION AT THE G1/S TRANSITION
    FLANAGAN, WM
    CRABTREE, GR
    IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS, 1993, 696 : 31 - 37
  • [25] THE ERYTHROPOIETIN-INDUCED PROLIFERATION OF HUMAN ENDOTHELIAL-CELL IS ASSOCIATED WITH P34(CDC2) KINASE ACTIVATION
    STEINER, M
    LEE, ES
    NOGUCHI, CT
    ANAGNOSTOU, A
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1083 - 1083
  • [26] Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34(cdc2)/cyclin B-1 activity induced by doxorubicin in synchronized P388 cells
    Ling, YH
    ElNaggar, AK
    Priebe, W
    PerezSoler, R
    MOLECULAR PHARMACOLOGY, 1996, 49 (05) : 832 - 841
  • [27] Fission yeast pheromone blocks S-phase by inhibiting the G(1) cyclin B-p34(cdc2) kinase
    Stern, B
    Nurse, P
    EMBO JOURNAL, 1997, 16 (03): : 534 - 544
  • [28] Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells
    Yang, Yong
    Hu, Yang
    Gu, Hong-Yan
    Lu, Na
    Liu, Wei
    Qi, Qi
    Zhao, Li
    Wang, Xiao-Tang
    You, Qi-Dong
    Guo, Qing-Long
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (11) : 1459 - 1463
  • [29] SCREENING FOR ANTIMITOTIC COMPOUNDS USING THE CDC25 TYROSINE PHOSPHATASE, AND ACTIVATOR OF THE MITOSIS-INDUCING P34(CDC2) CYCLIN-B(CDC13) PROTEIN-KINASE
    BARATTE, B
    MEIJER, L
    GALAKTIONOV, K
    BEACH, D
    ANTICANCER RESEARCH, 1992, 12 (03) : 873 - 880
  • [30] Immunohistochemical analysis of P34(CDC2) and cyclin B cell localization in recurrent head and neck squamous cell carcinoma after irradiation
    CohenJonathan, E
    Toulas, C
    Rochaix, P
    David, JF
    DalySchveitzer, N
    Favre, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 820 - 820